Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Moodys
QuintilesIMS
Covington
AstraZeneca
Novartis
UBS
Accenture
Colorcon

Generated: October 21, 2017

DrugPatentWatch Database Preview

Almotriptan malate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for almotriptan malate and what is the scope of almotriptan malate patent protection?

Almotriptan malate
is the generic ingredient in two branded drugs marketed by Janssen Pharms, Ajanta Pharma Ltd, Teva Pharms Usa, and Mylan Pharms Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for almotriptan malate. Six suppliers are listed for this compound.

Summary for Generic Name: almotriptan malate

US Patents:0
Tradenames:2
Applicants:4
NDAs:4
Drug Master File Entries: see list6
Suppliers / Packagers: see list6
Bulk Api Vendors: see list39
Clinical Trials: see list192
Patent Applications: see list337
Therapeutic Class:Antimigraine Agents
Drug Prices:see low prices
DailyMed Link:almotriptan malate at DailyMed

Pharmacology for Ingredient: almotriptan malate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205523-001Mar 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-002May 7, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL078027-002Jul 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205171-001Nov 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-001May 7, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205171-002Nov 9, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL078027-001Jul 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma Ltd
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL205523-002Mar 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: almotriptan malate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-001May 7, 2001► Subscribe► Subscribe
Janssen Pharms
AXERT
almotriptan malate
TABLET;ORAL021001-002May 7, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Deloitte
US Department of Justice
US Army
Cerilliant
Cantor Fitzgerald
Farmers Insurance
Julphar
Chubb
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot